TITAN PHARMACEUTICALS INC Business Finance Contracts & Agreements

86 Contracts & Agreements

Browse by Subcategory

Equity Distribution Agreements (1 contract)
Facility Agreements (1)
Loan Agreements (8)
Note Agreements (3)
Purchase Agreements (13)
Registration Rights Agreements (7)
Repurchase Agreements (2)
Security Agreements (1)
Share Agreements (1)
Stock Agreements (11)
Subscription Agreements (1)
Term Sheets (1)
Underwriting Agreements (8)
Warrant Agreements (28)

Recent Contracts

Convertible Promissory Note between Titan Pharmaceuticals, Inc. and Choong Choon Hau (Filed With SEC on November 14, 2023)
Form of Registration Rights Agreement, dated as of September 13, 2023, by and among the Company and The Sire Group Ltd (Filed With SEC on September 19, 2023)
Form of Securities Purchase Agreement, dated as of September 13, 2023, by and among the Company and The Sire Group Ltd (Filed With SEC on September 19, 2023)
Certificate of Designations, Preferences and Rights of Series AA Convertible Preferred Stock (Filed With SEC on September 19, 2023)
Form of Registration Rights Agreement, dated as of September 13, 2023, by and among the Company and The Sire Group Ltd (Filed With SEC on September 18, 2023)
Form of Securities Purchase Agreement, dated as of September 13, 2023, by and among the Company and The Sire Group Ltd (Filed With SEC on September 18, 2023)
Certificate of Designations, Preferences and Rights of Series AA Convertible Preferred Stock (Filed With SEC on September 18, 2023)
Convertible Promissory Note between Titan Pharmaceuticals, Inc. and Choong Choon Hau (Filed With SEC on August 14, 2023)
Unsecured Promissory Note between Titan Pharmaceuticals, Inc. and David E. Lazar (Filed With SEC on July 28, 2023)
Asset Purchase Agreement between Titan Pharmaceuticals, Inc. and Fedson, Inc., dated as of July 26, 2023 (Filed With SEC on July 28, 2023)
Form of Stock Option Agreement (Filed With SEC on November 14, 2022)
Form of Stock Option Agreement (Filed With SEC on September 21, 2022)
Form of Securities Purchase Agreement (Filed With SEC on February 3, 2022)
Form of Placement Warrant (Filed With SEC on February 3, 2022)
Form of Private Pre-Funded Warrant (Filed With SEC on February 3, 2022)
Form of Registered Pre-Funded Warrant (Filed With SEC on February 3, 2022)
Form of Securities Purchase Agreement (Filed With SEC on January 19, 2021)
Form of Warrant (Filed With SEC on January 19, 2021)
Asset Purchase Agreement dated October 27, 2020 between Titan Pharmaceuticals, Inc. and JT Pharmaceuticals, Inc (Filed With SEC on November 16, 2020)
Underwriting Agreement dated October 28, 2028 between Titan Pharmaceuticals, Inc. and Maxim Group LLC (Filed With SEC on November 2, 2020)
Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company and Form of Warrant (Filed With SEC on October 27, 2020)
Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company and Form of Warrant (Filed With SEC on October 26, 2020)
Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company and Form of Warrant (Filed With SEC on October 19, 2020)
Underwriting Agreement between Titan Pharmaceuticals, Inc. and Maxim Group LLC (Filed With SEC on October 19, 2020)
Form of Share Purchase Agreement (Filed With SEC on September 25, 2020)
Amendment No. 2 dated March 12, 2020 to Amended and Restated Venture Loan and Security Agreement, dated March 21, 2018, by and between Titan Pharmaceuticals, Inc., Horizon... (Filed With SEC on March 30, 2020)
Description of the Registrants Common Stock (Filed With SEC on March 30, 2020)
Form of March 3, 2020 Warrant Amendment Agreement (Filed With SEC on March 30, 2020)
Form of Securities Purchase Agreement (Filed With SEC on January 7, 2020)
Form of Warrant (Filed With SEC on January 7, 2020)
Class B Warrant Agency Agreement dated October 16, 2019 between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company (including Form of Class B Warrant) (Filed With SEC on October 18, 2019)
Underwriting Agreement dated October 16, 2019 between Titan Pharmaceuticals, Inc. and Maxim Group LLC (Filed With SEC on October 18, 2019)
Form of 2019 Class C Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer and Trust Company and Form of Class C Warrant (Filed With SEC on October 8, 2019)
Form of 2019 Class B Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company and Form of Class B Warrant (Filed With SEC on October 8, 2019)
Form of Underwriting Agreement between Titan Pharmaceuticals, Inc. and Maxim Group LLC (Filed With SEC on October 8, 2019)
Amendment No. 2 dated September 10, 2019 to Asset Purchase, Supply and Support Agreement by and between Titan Pharmaceuticals, Inc. and L. Molteni & C. Dei Frattelli Alitti Societ... (Filed With SEC on September 12, 2019)
Amendment dated September 10, 2019 to Amended and Restated Venture Loan and Security Agreement, dated March 21, 2018, by and between Titan Pharmaceuticals, Inc., Horizon... (Filed With SEC on September 12, 2019)
Form of 2019 Warrant Agency Agreement between Titan Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company and Form of Offering Warrant (Filed With SEC on September 12, 2019)
Form of Pre-Funded Warrant (Filed With SEC on September 12, 2019)
Form of Underwriting Agreement between Titan Pharmaceuticals, Inc. and Maxim Group LLC (Filed With SEC on September 12, 2019)